Abaxis Inc (NASDAQ:ABAX) reported a disappointing third-quarter fiscal 2014 with earnings per share of 14 cents missing both the Zacks Consensus Estimate and the year-ago earnings of 22 cents by a massive 31.8%. Abaxis Inc (NASDAQ:ABAX) stock opened at $34.29 in last session, and closed at $38.17, while the day range of ABAX stock is $33.62 – $39.35. The stock showed a negative weekly performance of -10.19%.
Breast health company Atossa Genetics Inc (NASDAQ:ATOS) reported on Wednesday the completion of its public offering of 5,834,234 units. Atossa Genetics Inc (NASDAQ:ATOS) stock opened at $2.53, in last session and closed at $2.47, by losing -3.52%. The 52 week range of ATOS is $1.74 – $12.40. Company’s market capitalization is $44.52million.
IDEXX Laboratories Inc (NASDAQ:IDXX) was downgraded by research analysts at Feltl & Co. from a “hold” rating to a “sell” rating in a report released on Thursday. IDEXX Laboratories, Inc. (NASDAQ:IDXX) stock advanced 0.44% and finished the last session at $114.26. The EPS of the stock remained 3.47. Company’s market capitalization is $5.93billion.
Quidel Corp (NASDAQ:QDEL) expects revenues in the fourth quarter of 2013 to be approximately $50 million. Quidel Corporation (NASDAQ:QDEL) stock opened the session at $30.06, and closed the session at $29.56. The 52 week range of the QDEL stock remained $20.27 – $32.24 and the day range was $28.76 – $30.82.